Alembic Pharmaceuticals Ltd.

Financial

	Alembic Pharma	Astrazeneca Pharma I	Jubilant Pharmova
Operational Metrics
Pharmaceutical Sector
US DMF Filings	140.0 .	n/a	98.0 .
Number of ANDA's Filed in USA	268.0 .	n/a	100.0 .
Number of ANDA's Approved By USFDA	223.0 .	n/a	62.0 .
Number of ANDA's Filed in Latam	14.0	n/a	n/a
Number of ANDA's Approved by Latam	4.0	n/a	n/a
Number of ANDA's Filed in South Africa	21.0	n/a	n/a
Number of ANDA's Approved by South Africa	7.0	n/a	n/a
Number of ANDA's Filed in Australia	17.0	n/a	n/a
Number of ANDA's Approved by Australia	14.0	n/a	n/a
Number of ANDA's Filed in Canada	21.0	n/a	24.0
Number of ANDA's Approved by Canada	20.0	n/a	24.0
Number of ANDA's Filed in Europe	21.0	n/a	38.0
Number of ANDA's Approved in Europe	19.0	n/a	37.0
R&D as a % of Total Sales	8.0 %	0.0	0.18 %
Financials
5 yr Average ROE	12.89 %	17.42 %	7.82 %
5yr average Equity Multiplier	1.39	1.99	1.96
5yr Average Asset Turnover Ratio	0.86	0.91	0.61
5yr Avg Net Profit Margin	11.15 %	9.65 %	6.45 %
Price to Book	3.63	26.91	2.69
P/E	31.23	113.04	36.54
5yr Avg Cash Conversion Cycle	9.46 Days	-6.33 Days	-39.98 Days
Inventory Days	99.1 Days	68.19 Days	74.06 Days
Days Receivable	66.32 Days	35.81 Days	45.59 Days
Days Payable	164.9 Days	187.52 Days	149.89 Days
5yr Average Interest Coverage Ratio	30.59	142.38	3.78
5yr Avg ROCE	15.26 %	23.84 %	8.15 %
5yr Avg Operating Profit Margin	17.29 %	14.57 %	16.76 %
5 yr average Debt to Equity	0.14	0.0	0.55
5yr CAGR Net Profit	-12.64 %	4.4 %	0.08 %
5yr Average Return on Assets	9.32 %	8.92 %	4.12 %
Shareholdings
Promoter Holding	69.67 %	75.0 %	47.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.06 %	0.0	-3.0 %
Change in Mutual Fund Holding (3 Yrs)	4.04 %	3.26 %	5.97 %

Business

	Alembic Pharma	Astrazeneca Pharma I	Jubilant Pharmova
Product Wise Break-Up	Product Wise Break-Up Formulations 84.75 Active Pharmaceutical Ingredient (API) 15.25 Clinical trials 0 Pharmaceutical products 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0	Product Wise Break-Up Pharmaceutical 93.72 Active Pharmaceutical Ingredient (API) 0 0 Specialty intermediates 0 Solid dosage formulations 0 Active pharmaceutical ingredients 0 Life science chemicals 0 0 Formulations 0 Clinical Trial 6.11 Nutritional products 0 India Branded pharmaceuticals 0 Allergy therapy products 0 Radiopharmaceuticals 0 Others 0.17	Product Wise Break-Up Pharmaceutical products 0 Active Pharmaceutical Ingredient (API) 0 Contract Manufacturing 16.81 Specialty intermediates 0 Solid dosage formulations 10.82 Active Pharmaceutical Ingredient (API) 9.26 Life science chemicals 0 Contract Research and Development Services 6.7 Formulations 0 Clinical trials 0 Nutritional products 0 India branded pharmaceuticals 0.72 Anti-allergic 10.21 Radiopharmaceuticals 44.9 Others 0.58
Product Wise Break-Up	Product Wise Break-Up Formulations 84.75 Active Pharmaceutical Ingredient (API) 15.25 Clinical trials 0 Pharmaceutical products 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0	Product Wise Break-Up Pharmaceutical 93.72 Active Pharmaceutical Ingredient (API) 0 0 Specialty intermediates 0 Solid dosage formulations 0 Active pharmaceutical ingredients 0 Life science chemicals 0 0 Formulations 0 Clinical Trial 6.11 Nutritional products 0 India Branded pharmaceuticals 0 Allergy therapy products 0 Radiopharmaceuticals 0 Others 0.17	Product Wise Break-Up Pharmaceutical products 0 Active Pharmaceutical Ingredient (API) 0 Contract Manufacturing 16.81 Specialty intermediates 0 Solid dosage formulations 10.82 Active Pharmaceutical Ingredient (API) 9.26 Life science chemicals 0 Contract Research and Development Services 6.7 Formulations 0 Clinical trials 0 Nutritional products 0 India branded pharmaceuticals 0.72 Anti-allergic 10.21 Radiopharmaceuticals 44.9 Others 0.58
Location Wise Break-Up	Location Wise Break-Up Rest of the World 60.76 India 39.24 China 0 Americas and Europe 0	Location Wise Break-Up China 0 Americas and Europe 0 India 93.61 Rest of the World 6.39	Location Wise Break-Up China 0 Americas and Europe 90.17 India 2.33 Rest of the World 7.5
Therapeutic Area Break-Up	Therapeutic Area Break-Up Gastrointestinal 0 Infection 0 Diabetes 0 Respiratory 0 Oncology 0 Cardiovascular 0 Others 100	Therapeutic Area Break-Up Oncology 69.5 Cardiac Science 20.0 Anti - Diabetes 6.1 Infection 0 Respiratory Systems 4.4 Gastrointestinal 0	-

Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd.

SIGN UP FOR FREE